News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
202,675 Results
Type
Article (13150)
Company Profile (62)
Press Release (189463)
Multimedia
Podcasts (3)
Webinars (3)
Section
Business (51241)
Career Advice (911)
Deals (8050)
Drug Delivery (15)
Drug Development (48018)
Employer Resources (59)
FDA (4831)
Job Trends (5069)
News (108636)
Policy (8173)
Tag
Academia (1113)
Accelerated approval (3)
Adcomms (7)
Allergies (64)
Alliances (16410)
ALS (41)
Alzheimer's disease (672)
Antibody-drug conjugate (ADC) (63)
Approvals (4872)
Artificial intelligence (90)
Autoimmune disease (21)
Automation (4)
Bankruptcy (30)
Best Places to Work (4718)
BIOSECURE Act (1)
Biosimilars (32)
Biotechnology (51)
Bladder cancer (63)
Brain cancer (16)
Breast cancer (150)
Cancer (1435)
Cardiovascular disease (57)
Career advice (763)
Career pathing (14)
CAR-T (104)
Cell therapy (255)
Cervical cancer (13)
Clinical research (40319)
Collaboration (362)
Compensation (81)
Complete response letters (4)
COVID-19 (1692)
CRISPR (18)
C-suite (67)
Cystic fibrosis (54)
Data (1425)
Decentralized trials (1)
Depression (20)
Diabetes (117)
Diagnostics (1715)
Digital health (8)
Diversity, equity & inclusion (18)
Drug discovery (46)
Drug pricing (13)
Drug shortages (3)
Duchenne muscular dystrophy (50)
Earnings (18801)
Editorial (6)
Employer branding (7)
Employer resources (51)
Events (30467)
Executive appointments (215)
FDA (5358)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (300)
Gene editing (40)
Generative AI (8)
Gene therapy (149)
GLP-1 (252)
Government (1545)
Grass and pollen (3)
Guidances (19)
Healthcare (7067)
Huntington's disease (11)
IgA nephropathy (19)
Immunology and inflammation (88)
Indications (18)
Infectious disease (1782)
Inflammatory bowel disease (82)
Influenza (33)
Intellectual property (36)
Interviews (140)
IPO (3865)
IRA (5)
Job creations (610)
Job search strategy (702)
Kidney cancer (8)
Labor market (5)
Layoffs (116)
Leadership (6)
Legal (814)
Liver cancer (33)
Lung cancer (219)
Lymphoma (109)
Machine learning (2)
Management (15)
Manufacturing (93)
MASH (32)
Medical device (1858)
Medtech (1860)
Mergers & acquisitions (4423)
Metabolic disorders (301)
Multiple sclerosis (56)
NASH (4)
Neurodegenerative disease (41)
Neuropsychiatric disorders (9)
Neuroscience (963)
NextGen: Class of 2025 (2169)
Non-profit (1743)
Obesity (147)
Opinion (69)
Ovarian cancer (61)
Pain (33)
Pancreatic cancer (57)
Parkinson's disease (88)
Partnered (6)
Patents (68)
Patient recruitment (65)
Peanut (44)
People (13398)
Pharmaceutical (10)
Pharmacy benefit managers (3)
Phase I (14898)
Phase II (18429)
Phase III (11283)
Pipeline (661)
Policy (26)
Postmarket research (933)
Preclinical (4249)
Press Release (17)
Prostate cancer (61)
Psychedelics (8)
Radiopharmaceuticals (97)
Rare diseases (169)
Real estate (1320)
Recruiting (23)
Regulatory (6716)
Reports (10)
Research institute (1220)
Resumes & cover letters (137)
Rett syndrome (5)
RSV (38)
Schizophrenia (43)
Series A (64)
Series B (31)
Service/supplier (2)
Sickle cell disease (19)
Special edition (2)
Spinal muscular atrophy (73)
Sponsored (16)
Startups (1113)
State (1)
Stomach cancer (10)
Supply chain (18)
Tariffs (8)
The Weekly (3)
Vaccines (554)
Venture capitalists (12)
Weight loss (81)
Women's health (8)
Worklife (4)
Date
Today (13)
Last 7 days (362)
Last 30 days (1017)
Last 365 days (13768)
2025 (4474)
2024 (14418)
2023 (16103)
2022 (19621)
2021 (20549)
2020 (19236)
2019 (15584)
2018 (11855)
2017 (10406)
2016 (9118)
2015 (10427)
2014 (6922)
2013 (5305)
2012 (5539)
2011 (5848)
2010 (4836)
Location
Africa (254)
Alabama (22)
Alaska (3)
Arizona (47)
Arkansas (4)
Asia (14088)
Australia (2414)
California (2561)
Canada (739)
China (274)
Colorado (106)
Connecticut (103)
Delaware (88)
Europe (30632)
Florida (383)
Georgia (71)
Idaho (21)
Illinois (177)
India (8)
Indiana (127)
Iowa (4)
Japan (66)
Kansas (25)
Kentucky (13)
Louisiana (1)
Maine (44)
Maryland (342)
Massachusetts (1936)
Michigan (51)
Minnesota (61)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (6)
Nevada (22)
New Hampshire (13)
New Jersey (767)
New Mexico (7)
New York (803)
North Carolina (299)
North Dakota (1)
Northern California (1192)
Ohio (62)
Oklahoma (1)
Oregon (13)
Pennsylvania (537)
Puerto Rico (2)
Rhode Island (16)
South America (370)
South Carolina (3)
South Dakota (1)
Southern California (931)
Tennessee (20)
Texas (390)
United States (9281)
Utah (48)
Virginia (76)
Washington D.C. (19)
Washington State (302)
West Virginia (2)
Wisconsin (15)
202,675 Results for "immune tolerance network".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center
START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials
March 20, 2025
·
1 min read
Press Releases
Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases
December 20, 2024
·
8 min read
Press Releases
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
October 16, 2024
·
6 min read
Press Releases
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
May 1, 2025
·
5 min read
Startups
GSK-backed Ouro Launches With $120M to ‘Reset’ the Immune System
Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated diseases.
January 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients
March 24, 2025
·
4 min read
Biotech Bay
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Repertoire® Immune Medicines announced that it has entered a multi-year strategic collaboration with Bristol Myers Squibb to develop tolerizing vaccines for up to three autoimmune diseases.
April 29, 2024
·
3 min read
Press Releases
IonQ Reaches Important Milestone in Achieving Faster Quantum Gates for Quantum Computing and Networking
March 5, 2025
·
6 min read
Press Releases
Adams Clinical Site Network Announces Promotion of Dr. Stephanie Rutrick to Chief Medical Officer
April 1, 2025
·
2 min read
Press Releases
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
November 14, 2024
·
11 min read
1 of 20,268
Next
